Attenuated stress-induced catecholamine release in mice lacking the vasopressin V 1b receptor

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 1, 2006, Pages

  Itoh, Shuji ^a   Yamada, Sakiko ^a   Mori, Toyoki ^a   Miwa, Takashi ^a   Tottori, Katsura ^a   Uwahodo, Yasufumi ^a   Yamamura, Yoshitaka ^a   Fukuda, Meiko ^a   Yamamoto, Koji ^a   Tanoue, Akito ^b   Tsujimoto, Gozoh ^c  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Dopamine; Epinephrine; Immobility time in the forced swimming test; Norepinephrine; V 1b receptor knockout mice

Indexed keywords

ADRENALIN; ARGIPRESSIN; CATECHOLAMINE; DOPAMINE; NORADRENALIN; VASOPRESSIN V1 RECEPTOR;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; GENOTYPE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RELEASE; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL ISOLATION; STRESS;

ANIMALS; ARGININE VASOPRESSIN; CATECHOLAMINES; DOPAMINE; EPINEPHRINE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOREPINEPHRINE; PITUITARY-ADRENAL SYSTEM; RECEPTORS, VASOPRESSIN; SOCIAL ISOLATION; STRESS; SWIMMING;

EID: 33745826273     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00005.2006     Document Type: Article

References (23)

1. Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14: 76-122, 1993.
2. Armando I, Lemoine AP, Ferrini M, Segura ET, and Barontini M. Repeated (isolation) stress increases tribulin-like activity in the rat. Cell Mol Neurobiol 9: 115-122, 1989.
3. Egashira N, Tanoue A, Higashihara F, Fuchigami H, Sano K, Mishima K, Fukue Y, Nagai H, Takano Y, Tsujimoto G, Stemmelin J, Griebel G, Iwasaki K, Ikeda T, Nishimura R, and Fujiwara M. Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs. Neuropsychopharmacology 30: 1996-2005, 2005.
4. Gallo-Payet N and Guillon G. Regulation of adrenocortical function by vasopressin. Horm Metab Res 30: 360-367, 1998.
5. Gold PW, Robertson GL, Ballernger JC, Goodwin FK, Rubinow DR, Kellner C, and Post RM. Neurohypophysial function in affective illness. Psychopharmacol Bull 19: 426-431, 1981.
6. Grazzini E, Lodboerer AM, Perez-Martin A, Joubert D, and Guillon G. Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla. Endocrinology 137: 3906-3914, 1996.
7. Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, and Soubrie P. Anxiolytic- and antidepressant-like effects of the nonpeptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci USA 99: 6370-6375, 2002.
8. Hernando F, Schoots O, Lolait SJ, and Burbach JP. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 142: 1659-1668, 2001.
9. Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, and Sawyer WH. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 30: 171-177, 1986.
10. Jeong KH, Jacobson L, Pacák K, Widmaier EP, Goldstein DS, and Majzoub JA. Impaired basal and restraint-induced epinephrine secretion in corticotropin releasing hormone-deficient mice. Endocrinology 141: 1142-1150, 2000.
11. Keyzer Y, Auzan C, Lenne F, Beldjord C, Thibonnier M, Bertagna X, and Clauser E. Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett 356: 215-220, 1994.
12. Lolait SJ, O'Carroll AM, McBride OW, Koning M, Morel A, and Brownstein MJ. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357: 336-339, 1992.
13. Morel A, O'Carroll AM, Brownstein MJ, and Lolait SJ. Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 356: 523-526, 1992.
14. Muller MB, Landgraf R, Preil J, Sillaber I, Kresse AE, Keck ME, Zimmermann S, Holsboer F, and Wurst W. Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. Endocrinology 141: 4262-4269, 2000.
15. Noda Y and Sasaki S. Molecular mechanisms and drug development in aquaporin water channel diseases: molecular mechanism of water channel aquaporin-2 trafficking. J Pharm Sci 96: 249-254, 2004.
16. Porsolt RD, Bertin A, and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327-336, 1977.
17. Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G, Barberis C, Brossard G, Soubrie P, Nisato D, Pascal M, Pruss R, Scatton B, Maffrand JP, and Le Fur G. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4- dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl] -4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. J Pharmacol Exp Ther 300: 1122-1130, 2002.
18. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, and Lee KF. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20: 1093-1102, 1998.
19. Tanoue A, Itoh S, Honda K, Oshikawa S, Kitagawa Y, Koshimizu T, Mori T, and Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest 113: 302-309, 2004.
20. Thibonnier M. Vasopressin and blood pressure. Kidney Int 34: S52-S56, 1988.
21. Turnbull AV, Smith GW, Lee S, Vale WW, Lee KF, and Rivier C. CRF type 1 receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology 140: 1013-1017, 1999.
22. Viskupic E, Kvetnansky R, Sabban EL, Fukuhara K, Weise VK, Kopin IJ, and Schwartz JP. Increase in rat adrenal phenylethanolamine N-methyltransferase mRNA level caused by immobilization stress depends on intact pituitary- adrenocortical axis. J Neurochem 63: 808-814, 1994.
23. Wersinger SR, Ginns EI, O'Carroll AM, Lolait SJ, and Young WS III. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol Psychiatry 7: 975-984, 2002.